Knight Therapeutics Announces Approval of Additional Indication for MINJUVI® (tafasitamab) in Brazil

MONTREAL, March 17, 2026 (GLOBE NEWSWIRE) — Knight Therapeutics Inc., (TSX: GUD) (“Knight”) a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltda. has received approval from ANVISA, the Brazilian health regulatory agency, for an additional indication for MINJUVI® (tafasitamab). The approval follows a supplemental regulatory filing and review by […]


34 h.
Science
ID: -2924605180102015792


Similar News expand_more


Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Technology
Science
Science
Science
Science
Technology
Crime
Science
Science
Science
Science
Science
Economics
Technology
Science
Science
Science
Technology
Science
Entertainment
Science
Science
Technology
Popular countries based on strong economic and political relations

Add Watch Country

arrow_drop_down